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Background: The aim of this study was to analyze the early postoperative outcome of esophageal cancer treated
by subtotal esophageal resection, gastric interposition and either intrathoracic or cervical anastomosis in a single
center study.
Methods: 72 patients who received either a cervical or intrathoracic anastomosis after esophageal resection for
esophageal cancer were matched by age and tumor stage. Collected data from these patients were analyzed
retrospectively regarding morbidity and mortality rates.
Results: Anastomotic leakage rate was significantly lower in the intrathoracic anastomosis group than in the
cervical anastomosis group (4 of 36 patients (11%) vs. 11 of 36 patients (31%); p = 0.040). The hospital stay was
significantly shorter in the intrathoracic anastomosis group compared to the cervical anastomosis group (14 (range
10–110) vs. 26 days (range 12 – 105); p = 0.012). Wound infection and temporary paresis of the recurrent laryngeal
nerve occurred significantly more often in the cervical anastomosis group compared to the intrathoracic
anastomosis group (28% vs. 0%; p = 0.002 and 11% vs. 0%; p = 0.046). The overall In-hospital mortality rate was 6%
(4 of 72 patients) without any differences between the study groups.
Conclusions: The present data support the assumption that the transthoracic approach with an intrathoracic
anastomosis compared to a cervical esophagogastrostomy is the safer and more beneficial procedure in patients
with carcinoma of the lower and middle third of the esophagus due to a significant reduction of anastomotic
leakage, wound infection, paresis of the recurrent laryngeal nerve and shorter hospital stay.
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TranshiatalBackground
Up to date two techniques of resection of the esophagus
are common [1,2]. In cases of cancer of the gastroeso-
phageal junction some authors prefer the transhiatal ap-
proach with collar anastomosis in order to reduce early
postoperative morbidity and mortality rates by avoiding
thoracotomy and potential mediastinitis erosed by anas-
tomotic leakage [3,4] despite an increased risk of leakage* Correspondence: cklink@ukaachen.de
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reproduction in any medium, provided the orand anastomotic stricture formation [5]. Others favour
the transthoracic resection to improve the cure rate by a
more aggressive approach in which a more radical medi-
astinal lymphadenectomy can be achieved [6].
One major challenge after esophageal resection
remains the occurrence of anastomotic leakage attended
by mortality rates up to 50% [7]. The incidence of anasto-
motic leakage varied widely (3 to 50%) [1] independently
of the placement of the anastomosis, which suggests that
it is potentially a definitional problem. Some authors only
count clinically significant leakages, whereas others also
include subclinical, only radiographically detected
leakages.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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outcome dependent on the surgical approach (either
transthoracic or transhiatal) [1,2] we tried to investigate
the influence of the position of the esophagogastrostomy
(either cervical or intrathoracic) in a single center
matched pair analysis.
Patients and methods
The matched pair analysis was performed at the Depart-
ment of General, Visceral and Transplantation Surgery,
University Hospital of the RWTH Aachen, Germany. The
study was conducted in accordance with the study proto-
col, the Declaration of Helsinki and applicable regulatory
requirements. The study was approved by the ethics com-
mittee of the faculty of medicine of the RWTH University
of Aachen. The approval number is EK 105/11.
Between June 2009 and June 2010 36 consecutive
patients received an esophageal resection due to esopha-
geal cancer in our department. All patients underwent
Ivor Lewis subtotal esophagectomy with two-field lymph
node dissection. In brief, all resections were performed
by initial abdominal exploration through an upper mid-
line laparotomy. The stomach was mobilized on the
right gastric and gastroepiploic arteries. The left gastric
artery was divided at its origin, and all lymph nodes
along the celiac axis and its three branches along the left
aspect of the portal vein, in front of the inferior vena
cava, along the diaphragmatic pillars were resected. A
pyloromyotomy was not performed routinely. With a
right anterolateral thoracotomy, the chest was entered
through the fifth intercostal space. The azygos vein arch
was divided, and the esophagus was dissected from eso-
phagogastric junction to the apex of the chest. Complete
lymph node dissection of the dorsal mediastinum in-
cluding subcarinal lymph nodes was performed. A resec-
tion of the thoracic duct was not performed routinely.
Denudation of the lesser curvature was usually per-
formed in the pleural cavity. After resection of the speci-
men, an end-to-side anastomosis was constructed
between the esophagus and the stomach. The anasto-
mosis was located in the apex of the chest and was deliv-
ered by a circular stapler device. None of the patients
were excluded.
For each patient in the intrathoracic group, patients
who received a cervical anastomosis in the time between
January 2007 and May 2009 were selected from our
database of patients (n = 60) in the same institution who
matched the following criteria: age and tumor stage.
Among patients with cervical anastomosis in case of
adenocarcinoma a transhiatal resection of the esophagus
with left-sided cervical hand sutured end-to-end esopha-
gogastric anastomosis was carried out, whereas in case
of squamous cell carcinoma abdomino-right-sided-thor-
acic resection with two-field lymphadenectomy and left-sided cervical hand sutured end-to-end esophagogastric
anastomosis was performed. Mobilisation of the gastric
tube and lymph node dissection was equal to the tech-
nique described above. All patients with thoracotomy
received a right-sided chest tube insertion.
Prospectively collected data from these patients were
reviewed retrospectively. The observation period was the
initial hospital stay. We analyzed the following clinical
markers representing the early perioperative outcome:
resected lymph nodes, operation time, intensive care stay
(ICU), re-ICU-stay, overall hospital stay, In-hospital mor-
tality, blood substitution intra- and postoperatively, post-
operative bleeding, pneumonia, need of postoperative
CPAP (non-invasive continuous positive airway pressure),
re-intubation, anastomotic leakage, revision operation,
wound infection, thrombemboli and chylothorax. In case
of postoperative dysphony a larnygoscopy was performed
to document potential laryngeal nerve palsy.
All patients were discussed at a weekly multidisciplin-
ary meeting, and treatment strategies were developed
and tailored for individual patients. In general, patients
with squamous cell carcinoma were offered neoadjuvant
radiochemotherapy in case of tumor stage II and III.
Since 2007 patients with adenocarcinoma (stage II and
III) received neoadjuvant chemotherapy according to the
MAGIC Trial [8].
Preoperatively, all patients received a thoracic peri-
dural catheter. After surgery, all patients returned to the
intensive care unit and were extubated on the same day.
All patients received a restrictive volume regime. All
patients received a nasojejunal feeding tube during sur-
gery which was removed on day 5 after surgery. Oral
feeding started on day 5 after surgery. Before return to
solid food a gastrografin swallowing (50 to 100 ml)
examination was performed in all patients. In case of
radiographically or clinically suspected anastomotic leak-
age endoscopy was performed. In cases of obvious leak-
age among patients with cervical anastomosis a nutrition
tube was inserted into the duodenum endoscopically for
enteral nutrition until spontaneous closure of the defect
occurred. In cases of leakage of thoracic anastomosis a
double-layered self-expandable stent was inserted with
patient under sedation. Each stent was individually
adapted in diameter and length dependent on the leak-
age size, and subjected to the distance between defect
and upper esophageal sphincter. The location of the
stent was visualized and controlled radiographically dur-
ing the implantation.
Statistical analysis
Means and standard deviations (notation: mean ± SD) as
well as frequencies and percentage were given to de-
scribe the data. In case of not normal distribution data is
represented as median and range. According to the
Klink et al. World Journal of Surgical Oncology 2012, 10:159 Page 3 of 5
http://www.wjso.com/content/10/1/159matched pairs study design, we used paired t-tests to
compare means between the intrathoracic and cervical
anastomosis groups, e.g. the mean ICU stay. Further the
Cochrane Mantel Haenszel test stratified by pairs was
used to compare proportions between the intrathoracic
and cervical anastomosis groups, e.g. proportion of anas-
tomotic leakage. Statistically significance was assessed if
the p-value of the corresponding test fell below the sig-
nificance level of 0.05. Due to the small sample size our
statistical analysis was limited to bivariate statistical ana-
lysis. Thus no stratified (multivariate) analysis could be
conducted because of lack of model fit. We used SASW
V9 under Windows XP for computations.Results
Patients’ preoperative characteristics including risk fac-
tors presented in Table 1 did not show any significantTable 1 Patients characteristics risk factors in
dependency of type of anastomosis
Intrathoracic
(n = 36)
Cervical
(n = 36)
p-value
Age 62± 12 62 ± 10
Gender
- male 34 (94%) 30 (83%) 0.157
- female 2 (6%) 6 (17%)
ASA-classification
−2 18 (50%) 19 (53%)
−3 18 (50%) 17 (47%) 0.819
Cardiac disease 9 (25%) 9 (25%) 1.000
Pulmonary disease 8 (22%) 10 (28%) 0.527
Hypertension 24 (67%) 19 (53%) 0.225
Diabetes 10 (28%) 8 (22%) 0.593
Abuse of nicotine 17 (47%) 17 (47%) 1.000
Abuse of alcohol 13 (36%) 13 (36%) 1.000
Histology
-adenocarcinoma 29 (81%) 26 (72%) 0.317
-squamous cell carcinoma 7 (19%) 10 (28%)
UICC stage
- I 16 (44%) 15 (42%)
-II 8 (22%) 9 (25%)
-III 10 (28%) 11 (31%)
-IV 2 (6%) 1 (3%)
Grading
2 15 (42%) 16 (44%) 0.796
3 21 (58%) 20 (56%)
Radiatio preoperative 6 (17%) 4 (11%) 0.414
Chemotherapy
preoperative
20 (56%) 7 (19%) 0.003differences between the two groups except the fact that
in the intrathoracic group significantly more patients
received preoperative chemotherapy than in the cervical
group (p = 0.003). 18 ± 8 lymph nodes were resected in
the intrathoracic group whereas 16 ± 7 lymph nodes
were resected in the cervical group (p = 0.539).
Neither operation time (261 ± 53 min vs. 238± 60 min;
p = 0.087) nor ICU stay (3.4 ± 6.7 days vs. 5.3 ± 6.9 days;
p = 0.232) revealed any statistical differences in-between
the intrathoracic and the cervical group. The median hos-
pital stay was significantly lower in the intrathoracic
group in comparison to the cervical group (14 (10 – 110)
vs. 26 (12 – 105); p = 0.012).
Complication rates were widely similar between the
groups (Table 2). Anastomotic leakage rate was signifi-
cantly lower in the intrathoracic group than in the cer-
vical group (11% vs. 31%; p = 0.040). Wound infection
and temporary paresis of recurrent laryngeal nerve oc-
curred significantly more often in the cervical group
than in the intrathoracic group (wound infection: 28%Table 2 Operation details and complications in
dependency of type of anastomosis
Intrathoracic
(n = 36)
Cervical
(n = 36)
p-value
Operation time in min 261 ± 53 238± 60 0.087
Thoracotomy 36 (100%) 7 (19%) <0.001
ICU stay in days 3.4 ± 6.7 5.3 ± 6.9 0.232
Re ICU 7 (19%) 6 (17%) 0.739
Median Hospital stay in days 14 (10 – 110) 26 (12 – 105) 0.012
In-hospital mortality 1 (3%) 3 (8%) 0.310
Blood transfusion
intraoperatively
6 (17%) 3 (8%) 0.317
Blood transfusion
postoperatively
8 (22%) 12 (33%) 0.248
Patients with lymph
nodes positive
17 (47%) 18 (50%) 0.655
Resected lymph nodes 18 ± 8 16± 7 0.539
Bleeding 1 (3%) 0 (0%) 0.317
Pneumonia 7 (19%) 7 (19%) 1.000
CPAP 10 (28%) 10 (28%) 1.000
Re-intubation 9 (25%) 9 (25%) 1.000
Anastomotic leakage 4 (11%) 11 (31%) 0.040
Revision operation 3 (8%) 2 (6%) 0.655
Wound infection 0 (0%) 10 (28%) 0.002
Thrombemboli 4 (11%) 3 (8%) 0.706
Paresis of recurrent
laryngeal nerve
0 (0%) 4 (11%) 0.046
Chylothorax 1 (3%) 1 (3%) 1.000
Radiatio postoperative 3 (8%) 3 (8%) 1.000
Chemotherapy postoperative 17 (47%) 10 (28%) 0.108
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geal nerve: 11% vs. 0%; p = 0.046). In 50% off all cases
the recurrent nerve paresis went to normal function
within 12 weeks. There was no significant difference
regarding blood substitution intraoperatively (17%
intrathoracic vs. 8% cervical; p = 0.317) and postopera-
tively (22% intrathoracic vs. 33% cervical; p = 0.248)
comparing study groups.
Discussion and conclusions
The present investigation is based on a total amount of
72 patients with esophageal cancer. Thirty six consecu-
tive patients who had undergone surgery for carcinoma
of the esophagus by an intrathoracic anastomosis, and
36 patients fulfilling matching criteria as stated above
who received esophageal resection including a cervical
anastomosis. Aim of this study was not only to compare
the operative procedures in a single center study but
also to serve as a quality assurance of our department
since therapeutic strategy was changed in 2009.
Matched pairs analysis is to be preferred in our setting,
because the comparison with an historical control group
is likely to be biased by heterogeneity between groups.
The matched pairs are similar in respect to the most im-
portant factors which may bias treatment differences.
Analyzing patients’ preoperative risk factors and charac-
teristics no significant differences in-between study
groups were found supporting the fact that matching
criteria were met. The intrathoracic group received sig-
nificantly more often chemotherapy pre- and postopera-
tively which is due to the fact that since 2007 patients
with adenocarcinoma (stage II and III) received neoadju-
vant chemotherapy according to Cunningham et al. [8].
However, although the intrathoracic group received pre-
operative chemotherapy significantly more often, the op-
erative complications rates were not higher than in the
cervical group without neoadjuvant treatment.
Whether the anastomosis should be performed cervi-
cally, allowing wider margins of resection and elevated
risk of paresis of recurrent laryngeal nerve, or whether
intrathoracic anastomosis is favoured, with decreased re-
section margins is still a debatable issue in reconstruction
after esophagectomy [9]. It is discussed controversially
whether intrathoracic anastomosis reduces anastomotic
leakage or not. While in many studies the occurrence of
anastomotic leakage was lower when applying an
intrathoracic anastomosis [1,10-14], others did not find
any differences between the two surgical procedures
[9,15,16]. In our series anastomotic leakage occurred in
21% of all patients favouring intrathoracic anastomosis in
comparison to cervical anastomosis (11% vs. 31%). A pos-
sible explanation might be that the intrathoracic place-
ment of the anastomosis offers a better blood supply of
the gastric interposition. Since all intrathoracicanastomosis were stapled and all cervical anastomosis
were hand-sewn the technique of anastomosis might have
an influence on leakage rates, although in other studies
no influence of the suture method on the leakage rate
was found [17-19]. In a systematic review of eight rando-
mized clinical trials no difference was found comparing
hand-sewn versus stapled techniques [20]. However, the
incidence of anastomotic leakage following esophageal
surgery varies widely (3% to 50%) also depending on the
definition of leakage [1].
According to many studies intrathoracic anastomosis
which is always associated with thoracotomy is accom-
panied by a higher risk for perioperative complications,
especially of pulmonary kind and higher mortality rates
[3,4,21]. In contrast to the findings we found widely
similar perioperative complication rates in our study
groups. Neither the presence of pulmonary complica-
tions nor the need of re-intubation was increased in the
intrathoracic group. One possible reason might be that
19% of the patients of the cervical group received a
thoracotomy as well. Wound infection was significantly
elevated in the cervical group since drainage of anasto-
motic leakage in case of cervical anastomosis is achieved
through the cervical wound. The In-hospital mortality
rate was slightly higher in the cervical anastomosis
group without reaching significant difference, which is
in accordance to Rindani et al. and Chasseray et al. who
found similar mortality rates for transthoracic and trans-
hiatal resections [22,23].
In our series the mean lymph node harvests following
each procedure were comparable with those reported by
other centres, which ranged from 9 to 31 [4,24]. Some
authors mentioned that a disadvantage of the transhiatal
resection is a reduced transthoracic lymph node dissec-
tion, which is unfortunately limited to the lower poster-
ior, mediastinal lymph nodes [25,26]. However, in
accordance to Morgan et al. we found a similar amount
of resected lymph nodes in both study groups [24].
High median hospital stay might be due to the fact
that patients with anastomotic leakage stayed signifi-
cantly longer than patients without anastomotic leakage
which is comparable to the findings of previous studies
[27]. Despite the assumption that a transthoracic ap-
proach with an intrathoracic anastomosis is considered
to be a more invasive procedure than a transhiatal ap-
proach with cervical anastomosis, we neither found a
prolonged ICU nor hospital stay. Although there might
be more reasons other than placement of the anasto-
mosis (e.g. introduction of fast track regime), the hos-
pital stay was significantly lower since the new
therapeutical strategy was established, indicating that the
placement of an intrathoracic anastomosis represents a
save and feasible routine procedure without higher peri-
operative complication rates in comparison to the
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et al. showed that there is currently insufficient evidence
to show a significant difference between cervical and
intrathoracic anastomosis with respect to post-operative
complications and hospital mortality [28].
In conclusion of our study, after subtotal esophagect-
omy the intrathoracic anastomosis compared to the col-
lar anastomosis seems to be slightly favourable in terms
of perioperative outcome. Due to the change of the sur-
gical approach we were able to reduce anastomotic leak-
age rates but not to improve the extent of mediastinal
nodal resection. No conclusions can be drawn from this
data concerning the long-term survival or long-term
complications like anastomotic stenosis.
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